HYYDF - HEXO Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
5.11
-0.74 (-12.65%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close5.85
Open5.84
Bid0.00 x 0
Ask0.00 x 0
Day's Range4.91 - 5.98
52 Week Range3.05 - 7.17
Volume1,319,293
Avg. Volume816,565
Market Cap1.004B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 4 Marijuana Stocks From a Budding Industry
    InvestorPlace5 days ago

    4 Marijuana Stocks From a Budding Industry

    Emerging businesses often serve as excellent chances to earn outsized profits. One rising out of the shadows recently is the marijuana industry. Bans instituted in the early 20th century drove its cultivation and use of cannabis underground. However, with various trends toward legalization, marijuana stocks have gained interest from investors.

  • ACCESSWIRE23 days ago

    Don't Let Tilray Scare You, Pot Stocks are Here to Stay

    HENDERSON, NV / ACCESSWIRE / September 28, 2018 / Pot smokers have been buzzing about marijuana for years, medicinal almost as long and for the past few years investors have been loving this almost legal ...

  • 4 Medical Marijuana Stocks to Buy as the U.S. Chills Out
    InvestorPlace25 days ago

    4 Medical Marijuana Stocks to Buy as the U.S. Chills Out

    A permissive medical marijuana law received voter approval in Oklahoma earlier this year. Also, Republicans in Texas recently approved medical marijuana in their party platform. When this status changes, investing in medically-related marijuana stocks could reach a fever pitch in the fourth quarter and beyond.

  • Global Cannabis Partnership Welcomes New Members
    CNW Grouplast month

    Global Cannabis Partnership Welcomes New Members

    SAINT JOHN, NB , Sept. 13, 2018 /CNW/ - Momentum continues to build for the establishment of a Responsible Cannabis Framework as eight more organizations join the Global Cannabis Partnership (GCP), in its newly opened Member category. "We expect membership to expand as more and more stakeholders recognize the necessity of social responsibility policies and programs and want to be at the table to collaborate," says Kim Wilson , Executive Director of the GCP.

  • Global Cannabis Partnership Welcomes New Members
    PR Newswirelast month

    Global Cannabis Partnership Welcomes New Members

    SAINT JOHN, NB, Sept. 13, 2018 /PRNewswire/ - Momentum continues to build for the establishment of a Responsible Cannabis Framework as eight more organizations join the Global Cannabis Partnership (GCP), in its newly opened Member category. "We expect membership to expand as more and more stakeholders recognize the necessity of social responsibility policies and programs and want to be at the table to collaborate," says Kim Wilson, Executive Director of the GCP.

  • 2 Small-Cap Marijuana Stocks Poised for Big Gains
    Motley Fool2 months ago

    2 Small-Cap Marijuana Stocks Poised for Big Gains

    MariMed and the Hydropothecary Corporation could be incredible growth vehicles for early investors.

  • Organigram’s Consensus Price Target Rose in August
    Market Realist2 months ago

    Organigram’s Consensus Price Target Rose in August

    Organigram (OGRMF) is among the top gainers compared to cannabis companies (HMMJ) such as Canopy Growth (WEED) (CGC) and Hydropothecary (HYYDF), both of which have delivered positive YTD returns. Organigram has returned about 14% YTD as of August 7. The consensus ratings on Organigram also remained unchanged month-over-month as of August 7.

  • How Analysts Rate Hydropothecary in August
    Market Realist2 months ago

    How Analysts Rate Hydropothecary in August

    Hydropothecary (HYYDF) has done much better than other cannabis producers (HMMJ) such as Cronos (CRON), Aphria (APHQF), and Aurora Cannabis (ACB) (ACBFF). The stock has returned about 4.9% YTD (year-to-date) as of August 7, and it is one of the few cannabis stocks to be in the positive territory so far this year. Interestingly, more analysts are covering the stock compared to Aurora Cannabis.

  • 7 Things You Should Know About Hydropothecary Corporation's Q3 Results
    Motley Fool4 months ago

    7 Things You Should Know About Hydropothecary Corporation's Q3 Results

    Investors learned a lot about Hydropothecary if they looked beyond its top- and bottom-line results.

  • Better Marijuana Stock: Canopy Growth Corporation vs. The Hydropothecary Corporation
    Motley Fool4 months ago

    Better Marijuana Stock: Canopy Growth Corporation vs. The Hydropothecary Corporation

    Does size really matter when picking between these two marijuana stocks?

  • Flavor Of The Month: Alamos Gold And More
    Simply Wall St.5 months ago

    Flavor Of The Month: Alamos Gold And More

    Why invest in a stock whose growth outlook that lags behind the market? Investors looking for companies with extraordinary future prospects in terms of profitability and returns should look atRead More...

  • 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
    Motley Fool5 months ago

    8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production

    The number of major players in Canada's weed industry continues to expand.

  • These Stocks Were the Top Movers in the Cannabis Sector Last Week
    Market Realist5 months ago

    These Stocks Were the Top Movers in the Cannabis Sector Last Week

    Last week, the cannabis sector was broadly positive with the ETF Horizons Marijuana Life Sciences ETF (HMMJ) rising ~4.3%, the Evolve Marijuana ETD (SEED) rising 3%, the ETFMG Alternative Harvest ETF (MJ) rising 1.3%, and the Emerging Marijuana Growers Index ETF (HMJR) rising 0.4% between the close on May 11 and the close on May 18. Over the same period, the TSE 300 Index gained about 1.1%, while the S&P 500 Index fell 0.5%. Let’s look at how some of the cannabis stocks performed last week.

  • Analyst Price Target on Organigram Suggests Strong Upside
    Market Realist5 months ago

    Analyst Price Target on Organigram Suggests Strong Upside

    Organigram (ORGMF) has been among the few cannabis stocks that have a positive YTD (year-to-date) return of 15.6% as of May 16. The company announced its portfolio of offerings for the recreational cannabis consumers (HMLSF) following legalization in Canada. The offerings include organically cultivated cannabis under the Ankr Organics brand, cannabis for experienced users along with premium strains under the Edison brand, cannabis for value-oriented (price sensitive) consumers under the Trailer Park Buds brand, and medical cannabis under the OrganiGram brand.

  • 7 Pot Stocks on Track to Deliver in Excess of 100,000 Kilograms of Cannabis a Year
    Motley Fool5 months ago

    7 Pot Stocks on Track to Deliver in Excess of 100,000 Kilograms of Cannabis a Year

    Now introducing the marijuana industry's biggest players.

  • Canopy Growth Rose 10% Yesterday: Why?
    Market Realist6 months ago

    Canopy Growth Rose 10% Yesterday: Why?

    Yesterday, April 30, Canopy Growth (WEED) rose 10% and closed the day at $30.10 Canadian. The broader cannabis market was also higher with the Horizons Marijuana Life Science ETF (HMMJ) ending the day 3% higher and Aurora Cannabis (ACB), MedReleaf (MEDFF), and Hydropothecary (HYYDF) each gaining 6%. What moved cannabis stocks?

  • This Under-the-Radar Pot Stock Just Secured Canada's Largest Supply Agreement
    Motley Fool6 months ago

    This Under-the-Radar Pot Stock Just Secured Canada's Largest Supply Agreement

    Previously announced recreational cannabis supply agreements are peanuts next to this deal.

  • The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades
    Market Realist6 months ago

    The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades

    The cannabis sector remains hot for mergers and acquisitions as companies rush to capture a piece of the recreational cannabis market. Last week, Canopy Growth (WEED) announced that it had acquired Annabis Medical, an importer and distributor of medical cannabis in the Czech Republic. Last week, Cannabis Wheaton announced its acquisition of a licensed producer in Nova Scotia, Robinson’s Cannabis, which is constructing a 27,700-square-foot facility ahead of the legalization of recreational cannabis in Canada.

  • Hydropothecary: Analyst Ratings and Price Target in April
    Market Realist6 months ago

    Hydropothecary: Analyst Ratings and Price Target in April

    Hydropothecary (HYYDF) continued its upward momentum and closed 1.5% higher on April 12, 2018. The company and its peers (MJ) Canopy Growth (WEED), Aphria (APHQF), MedReleaf (MEDFF), and Aurora Cannabis (ACB) completed supply agreements with SAQ (Société des alcools du Québec). You can find out more at Why Hydropothecary Stock Rose 13% Yesterday.

  • Why Hydropothecary Stock Rose 13% Yesterday
    Market Realist6 months ago

    Why Hydropothecary Stock Rose 13% Yesterday

    On April 11, Hydropothecary (HYYDF) stock surged 13.2% after it became the SAQ’s (Société des alcools du Québec) preferred non-medical cannabis supplier once non-medical cannabis becomes legal in Canada. The company’s press release stated that the agreement term extends to the first five years following legalization and has an option to extend for another year.

  • Hydropothecary’s Operating Expense Swells in Fiscal 2Q18
    Market Realist7 months ago

    Hydropothecary’s Operating Expense Swells in Fiscal 2Q18

    Hydropothecary (HYYDF) reported a fall during fiscal 2Q18 due to a big increase in its operating expense YoY (year-over-year). The company’s operating expense rose from 1.7 million Canadian dollars in fiscal 2Q17 to 5.5 million Canadian dollars in fiscal 2Q18. Standardizing this as a percentage of its sales, Hydropothecary’s operating expenses rose from 1.9x its sales in fiscal 2Q17 to 4.6x its sales in fiscal 2Q18.

  • Hydropothecary’s Selling Price per Gram Drops in Fiscal 2Q18
    Market Realist7 months ago

    Hydropothecary’s Selling Price per Gram Drops in Fiscal 2Q18

    Key Takeaways from Hydropothecary's Fiscal 2Q18 Earnings

  • A Perspective on Hydropothecary’s Revenue Visibility
    Market Realist7 months ago

    A Perspective on Hydropothecary’s Revenue Visibility

    Earlier in this series, we learned that Hydropothecary (HYYDF) experienced a 29% YoY (year-over-year) increase in sales in its fiscal 2Q18. Driving this sales figure higher was the 45% YoY growth in the medical cannabis space. In all, the company sold 132,000 grams (or ~132 kilograms) of medical cannabis during the quarter.

  • Key Takeaways from Hydropothecary’s Fiscal 2Q18 Earnings
    Market Realist7 months ago

    Key Takeaways from Hydropothecary’s Fiscal 2Q18 Earnings

    Key Takeaways from Hydropothecary's Fiscal 2Q18 EarningsFiscal 2Q18 earnings

  • March Top Growth Companies
    Simply Wall St.7 months ago

    March Top Growth Companies

    Companies that have significant growth prospects for profitability and returns can add tangible upside to your portfolio. Real Matters and Distinct Infrastructure Group are examples of many potential outperformers thatRead More...